GENE ONLINE|News &
Opinion
Blog

Orphan Drugs & Rare Diseases
From Speed to System: When Data, AI, and IP Become APAC’s Innovation Moat
2026-02-04
Moderna and Recordati Form Strategic Alliance to Commercialize mRNA Therapy for Propionic Acidemia
2026-02-04
The Paradox of Possibilities: Scaling Precision in the Global Laboratory of the East
2026-02-04
From CRISPR to National Security: How Rare Diseases Became America’s Next Strategic Industry
2026-02-03
Beyond the 5%: Breaking Europe’s Decade of Rare Disease Stagnation
2026-02-03
Sanofi’s Venglustat Demonstrates Superiority Over ERT in Phase 3 Type 3 Gaucher Disease Trial
2026-02-02
[Illustrations] The Global and Taiwan Orphan Drug Market Heads Into 2026 With New Rules, New Prices, and New Pressure Points
2026-01-29
From Pipeline to Payday: The Rare Disease Assets Most Likely to Spark a 2026 M&A Land-Grab
2026-01-13
LATEST
The Operational Singularity and the Rise of Autonomous Medical Agents at WHX Dubai 2026
2026-02-09
Ouster Completes Acquisition of StereoLabs to Advance Physical AI Sensing and Perception Technology
2026-02-09
Adyen and Uber Expand Partnership to Launch Kiosks and Enhance Payment Solutions in Emerging Markets
2026-02-09
Chronic Alcohol Consumption Alters Gene Expression in Brain Regions Linked to Reward and Decision-Making
2026-02-09
GLP-1 Recombinant Analogs Advance as Targeted Therapies for Diabetes and Obesity
2026-02-09
Report Highlights Collaborative Care Needs for Alzheimer’s and Dementia Patients
2026-02-09
Novartis Begins Construction on Biomedical Research Facility in San Diego
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top